| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Recombinant human proNGF (cleavage resistant) protein from ALOMONE LABS | N-285 | 10 µg | ALOMONE LABS |
| Recombinant human proNGF (cleavage resistant) protein from ALOMONE LABS | N-285 | 25 µg | ALOMONE LABS |
| Recombinant human proNGF (cleavage resistant) protein from ALOMONE LABS | N-285 | 50 µg | ALOMONE LABS |
| Recombinant human proNGF (cleavage resistant) protein from ALOMONE LABS | N-285 | 0.1 mg | ALOMONE LABS |
| Recombinant human proNGF (cleavage resistant) protein from ALOMONE LABS | N-285 | 0.25 mg | ALOMONE LABS |
| Recombinant human proNGF (cleavage resistant) protein from ALOMONE LABS | N-285 | 0.5 mg | ALOMONE LABS |
| Recombinant human proNGF (cleavage resistant) protein from ALOMONE LABS | N-285 | 1 mg | ALOMONE LABS |
| Recombinant human proNGF protein from ALOMONE LABS | N-280 | 2 µg | ALOMONE LABS |
| Recombinant human proNGF protein from ALOMONE LABS | N-280 | 5 µg | ALOMONE LABS |
| Recombinant human proNGF protein from ALOMONE LABS | N-280 | 25 µg | ALOMONE LABS |
| Recombinant human proNGF protein from ALOMONE LABS | N-280 | 10 µg | ALOMONE LABS |
| Recombinant human proNGF protein from ALOMONE LABS | N-280 | 0.1 mg | ALOMONE LABS |
| Recombinant human proNGF protein from ALOMONE LABS | N-280 | 50 µg | ALOMONE LABS |
| 5,7-Dichlorokynurenic acid from ALOMONE LABS | D-190 | 10 mg | ALOMONE LABS |
| 5,7-Dichlorokynurenic acid from ALOMONE LABS | D-190 | 25 mg | ALOMONE LABS |
| 5,7-Dichlorokynurenic acid from ALOMONE LABS | D-190 | 50 mg | ALOMONE LABS |
| 5,7-Dichlorokynurenic acid from ALOMONE LABS | D-190 | 100 mg | ALOMONE LABS |
| 5,7-Dichlorokynurenic acid monohydrate from ALOMONE LABS | D-191 | 10 mg | ALOMONE LABS |
| 5,7-Dichlorokynurenic acid monohydrate from ALOMONE LABS | D-191 | 25 mg | ALOMONE LABS |
| 5,7-Dichlorokynurenic acid monohydrate from ALOMONE LABS | D-191 | 100 mg | ALOMONE LABS |
| 5,7-Dichlorokynurenic acid monohydrate from ALOMONE LABS | D-191 | 50 mg | ALOMONE LABS |
| 1,1-Dimethyl-4-phenylpiperazinium iodide from ALOMONE LABS | D-125 | 1 g | ALOMONE LABS |
| 1,1-Dimethyl-4-phenylpiperazinium iodide from ALOMONE LABS | D-125 | 5 g | ALOMONE LABS |
| 1,1-Dimethyl-4-phenylpiperazinium iodide from ALOMONE LABS | D-125 | 10 g | ALOMONE LABS |
| CGS 19755 from ALOMONE LABS | C-310 | 5 mg | ALOMONE LABS |
| CGS 19755 from ALOMONE LABS | C-310 | 10 mg | ALOMONE LABS |
| CGS 19755 from ALOMONE LABS | C-310 | 25 mg | ALOMONE LABS |
| CGS 19755 from ALOMONE LABS | C-310 | 50 mg | ALOMONE LABS |
| CGS 20625 from ALOMONE LABS | C-390 | 5 mg | ALOMONE LABS |
| CGS 20625 from ALOMONE LABS | C-390 | 10 mg | ALOMONE LABS |
| CGS 20625 from ALOMONE LABS | C-390 | 25 mg | ALOMONE LABS |
| CGS 20625 from ALOMONE LABS | C-390 | 50 mg | ALOMONE LABS |
| Recombinant human TNF-alpha protein from ALOMONE LABS | T-100 | 0.1 mg | ALOMONE LABS |
| Recombinant human TNF-alpha protein from ALOMONE LABS | T-100 | 0.25 mg | ALOMONE LABS |
| Recombinant human TNF-alpha protein from ALOMONE LABS | T-100 | 0.5 mg | ALOMONE LABS |
| Recombinant human TNF-alpha protein from ALOMONE LABS | T-100 | 1 mg | ALOMONE LABS |
| Recombinant human TNF-alpha protein from ALOMONE LABS | T-100 | 2 mg | ALOMONE LABS |
| Huwentoxin-I from ALOMONE LABS | STH-050 | 0.1 mg | ALOMONE LABS |
| Huwentoxin-I from ALOMONE LABS | STH-050 | 0.5 mg | ALOMONE LABS |
| Huwentoxin-I from ALOMONE LABS | STH-050 | 1 mg | ALOMONE LABS |
| Huwentoxin-I from ALOMONE LABS | STH-050 | 5 mg | ALOMONE LABS |
| Huwentoxin-I from ALOMONE LABS | STH-050 | 10 mg | ALOMONE LABS |
| Huwentoxin-I from ALOMONE LABS | STH-050 | 50 µg | ALOMONE LABS |
| Huwentoxin-IV from ALOMONE LABS | STH-100 | 0.1 mg | ALOMONE LABS |
| Huwentoxin-IV from ALOMONE LABS | STH-100 | 0.25 mg | ALOMONE LABS |
| Huwentoxin-IV from ALOMONE LABS | STH-100 | 0.5 mg | ALOMONE LABS |
| Huwentoxin-IV from ALOMONE LABS | STH-100 | 1 mg | ALOMONE LABS |
| Huwentoxin-IV from ALOMONE LABS | STH-100 | 5 mg | ALOMONE LABS |
| SLIGKV-NH2 from ALOMONE LABS | GPS-100 | 1 mg | ALOMONE LABS |
| SLIGKV-NH2 from ALOMONE LABS | GPS-100 | 5 mg | ALOMONE LABS |